These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1359594)

  • 1. Dopaminergic responsivity during cocaine abstinence: a pilot study.
    McDougle CJ; Price LH; Palumbo JM; Kosten TR; Heninger GR; Kleber HD
    Psychiatry Res; 1992 Jul; 43(1):77-85. PubMed ID: 1359594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study.
    Satel SL; Price LH; Palumbo JM; McDougle CJ; Krystal JH; Gawin F; Charney DS; Heninger GR; Kleber HD
    Am J Psychiatry; 1991 Dec; 148(12):1712-6. PubMed ID: 1957935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical ratings and plasma HVA during cocaine abstinence.
    Martin SD; Yeragani VK; Lodhi R; Galloway MP
    Biol Psychiatry; 1989 Aug; 26(4):356-62. PubMed ID: 2765598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma homovanillic acid and the dopamine transporter during cocaine withdrawal.
    Bowers MB; Malison RT; Seibyl JP; Kosten TR
    Biol Psychiatry; 1998 Feb; 43(4):278-81. PubMed ID: 9513737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A placebo-controlled trial of L-dopa/carbidopa in early cocaine abstinence.
    Wolfsohn R; Sanfilipo M; Angrist B
    Neuropsychopharmacology; 1993 Aug; 9(1):49-53. PubMed ID: 8397723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine measures of dopaminergic function in chronic cocaine users.
    Lee MA; Bowers MM; Nash JF; Meltzer HY
    Psychiatry Res; 1990 Aug; 33(2):151-9. PubMed ID: 2243892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of apomorphine on blood levels of homovanillic acid, growth hormone and prolactin in medicated schizophrenics and healthy control subjects.
    Scheinin M; Syvälahti EK; Hietala J; Huupponen R; Pihlajamäki K; Seppälä OP; Säkö E
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):441-9. PubMed ID: 2866563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.
    Camanni F; Picotti GB; Massara F; Molinatti GM; Mantegazza P; Müller EE
    J Clin Endocrinol Metab; 1978 Sep; 47(3):647-52. PubMed ID: 263317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic sensitivity and cocaine abuse: response to apomorphine.
    Hollander E; Nunes E; DeCaria CM; Quitkin FM; Cooper T; Wager S; Klein DF
    Psychiatry Res; 1990 Aug; 33(2):161-9. PubMed ID: 2243893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of 6-pyruvoyl-tetrahydropterin synthase deficiency demonstrates a more significant correlation of L-Dopa dosage with serum prolactin levels than CSF homovanillic acid levels.
    Ogawa A; Kanazawa M; Takayanagi M; Kitani Y; Shintaku H; Kohno Y
    Brain Dev; 2008 Jan; 30(1):82-5. PubMed ID: 17590551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurohormonal and behavioral response to methylphenidate in cocaine abstinence.
    Elangovan N; Barbato M; Cooper T; Winsberg B
    Psychiatry Res; 1996 Nov; 65(2):65-71. PubMed ID: 9122287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central nervous system and pituitary mechanisms in dopaminergic stimulation of growth hormone release in women.
    Ferrari C; Caldara R; Barbieri C; Testori GP; Benco R; Trezzi R; Crossignani RM; Rampini P
    Neuroendocrinology; 1981 Apr; 32(4):213-6. PubMed ID: 7219673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone and prolactin stimulation by Madopar in Parkinson's disease.
    Martinez-Campos A; Giovannini P; Parati E; Novelli A; Caraceni T; Müller EE
    J Neurol Neurosurg Psychiatry; 1981 Dec; 44(12):1116-23. PubMed ID: 7334406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of alpha-methyl-para-tyrosine on response to cocaine challenge.
    Stine SM; Krystal JH; Petrakis IL; Jatlow PI; Heninger GR; Kosten TR; Charney DS
    Biol Psychiatry; 1997 Aug; 42(3):181-90. PubMed ID: 9232210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral benzodiazepine receptors are decreased during cocaine withdrawal in humans.
    Javaid JI; Notorangelo MP; Pandey SC; Reddy PL; Pandey GN; Davis JM
    Biol Psychiatry; 1994 Jul; 36(1):44-50. PubMed ID: 8080902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot trial of levodopa/carbidopa in early cocaine abstinence.
    Wolfsohn R; Angrist B
    J Clin Psychopharmacol; 1990 Dec; 10(6):440-2. PubMed ID: 2286717
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroendocrine aspects in monitoring of dopaminergic drugs in man.
    Hietala J; Koulu M; Scheinin M; Syvälahti E
    Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):451-4. PubMed ID: 3935892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical alterations of dopamine receptor responses following chronic L-dopa therapy.
    Wilner KD; Butler IJ; Seifert WE; Clement-Cormier YC
    Biochem Pharmacol; 1980 Mar; 29(5):701-6. PubMed ID: 20227943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noradrenergic dysregulation during discontinuation of cocaine use in addicts.
    McDougle CJ; Black JE; Malison RT; Zimmermann RC; Kosten TR; Heninger GR; Price LH
    Arch Gen Psychiatry; 1994 Sep; 51(9):713-9. PubMed ID: 8080348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotrophin and prolactin responses to thyrotrophin-releasing hormone in patients with Parkinson's disease.
    Martinez-Campos A; Giovannini P; Novelli A; Cocchi D; Caraceni T; Müller EE
    Acta Endocrinol (Copenh); 1982 Mar; 99(3):344-51. PubMed ID: 6803485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.